Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

American Heart Journal

Volumn 156, Issue 3, 2008, Pages 588-594

  Eggers, Kai M ^a   Lagerqvist, Bo ^a   Oldgren, Jonas ^a   Venge, Per ^a   Wallentin, Lars ^a   Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; DALTEPARIN; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; TIME FACTORS; TROPONIN I; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 50549092622     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.04.022     Document Type: Article

References (24)

1. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
2. Lindahl B., Venge P., and Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 93 (1996) 1651-1657
3. Jeremias A., and Gibson M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142 (2005) 786-791
4. Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
5. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. Ongoing myocardial injury in stable severe heart failure. Value of cardiac troponin T monitoring for high-risk patient identification. Circulation 110 (2004) 2376-2382
6. Latini R., Masson S., Anand I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116 (2007) 1242-1249
7. Eggers K.M., Lagerqvist B., Venge P., et al. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts adverse long-term outcome. Circulation 116 (2007) 1907-1914
8. The Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 354 (1999) 708-715
9. Lagerqvist B., Husted S., Kontny F., et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368 (2006) 998-1004
10. Eggers KM, Lind L, Ahlström H, et al. Prevalence and pathophysiologic mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J [In press].
11. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 48 (2002) 869-876
12. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
13. Cockgroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
14. Oldgren J., Fellenius C., Boman K., et al. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease. J Intern Med 258 (2005) 420-427
15. Zethelius B., Johnston N., and Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year old men. Circulation 113 (2006) 1071-1078
16. Wallace T.W., Abdullah S.M., Drazner M.H., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 113 (2006) 1958-1965
17. Freda B.J., Tang W.H., Van Lente F., et al. Cardiac troponins in renal insufficiency. J Am Coll Cardiol 40 (2002) 2065-2071
18. Parikh N.I., Hwang S.J., Larson M.G., et al. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166 (2006) 1884-1894
19. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
20. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812 [Erratum in: J Clin Invest 2003;112:299]
21. Zairis M.N., Papadaki O.A., Manousakis S.J., et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 164 (2002) 355-359
22. Nilsson J.C., Groenning B.A., Nielsen G., et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J 143 (2002) 696-702
23. Chandrashekhar Y., Sen S., Anway R., et al. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43 (2004) 295-301
24. Eggers K.M., Lagerqvist B., Venge P., et al. Pathophysiologic mechanisms and prognostic value of persisting cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Eur Heart J 28 Suppl (2007) 64